Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celgene Corp Raises FY 2012 EPS Guidance; Narrows FY 2012 Revenue Guidance To A Range In Line With Analysts' Estimates


Thursday, 25 Oct 2012 07:41am EDT 

Celgene Corp announced that it has raised fiscal 2012 earnings guidance and narrowed revenue guidance. The Company expects adjusted diluted EPS to increase approximately 29% year-over-year to a range of $4.85 to $4.90, up from a previous range of $4.80 to $4.85. Total revenue is expected to increase approximately 14% year-over-year to a range of $5,450 to $5,550 million. The previous range was $5,400 to $5,600 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $5.499 billion and EPS of $4.88 for fiscal 2012. 

Company Quote

93.85
0.58 +0.62%
19 Sep 2014